Chancery Drops Suit Over Biopharma Firm's Cholesterol Drug
A Delaware vice chancellor on Thursday tossed a derivative suit against biopharmaceutical company Esperion Therapeutics Inc. that alleged its officers purposely misled the public about the prospects of a cholesterol-lowering drug...To view the full article, register now.
Already a subscriber? Click here to view full article